Related references
Note: Only part of the references are listed.Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
Patricia Perez-Galan et al.
BLOOD (2011)
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Matthew J. Maurer et al.
BLOOD (2011)
Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma
Matthew J. Maurer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia
Zeynep A. Yegin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related Lymphoma
Ola Landgren et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
Jenny Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia
Raphael Itzykson et al.
HAEMATOLOGICA (2008)
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Marie-Christine Kyrtsonis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Serum-free light chain - a new biomarker for patients with B-cell non-Hodgkin lymphocytic leukemia
William Martin et al.
TRANSLATIONAL RESEARCH (2007)
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli et al.
BLOOD (2006)
Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials
Mark Drayson et al.
BLOOD (2006)
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2006)
Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma
SY Kang et al.
ANNALS OF HEMATOLOGY (2005)
Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
M Drayson et al.
BLOOD (2001)
Share Paper
